Dr. David Deibert, MD (he/him) is an Endocrinologist in Wyomissing, PA with over 15 years of experience. What is your opinion of Dr. David Deibert, MD? Rate this provider below so other people can make informed decision.
Over 15 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. David Deibert, MD has received over $7,567 which includes payments from the following companies:
$938.70 from Novo Nordisk Inc
$854.03 from sanofi-aventis U.S. LLC
$755.88 from AbbVie, Inc.
$658.09 from LILLY USA, LLC
$517.38 from Amarin Pharma Inc.
$511.63 from INSULET CORPORATION
$440.44 from Valeritas, Inc.
$369.76 from AstraZeneca Pharmaceuticals LP
$335.56 from Janssen Pharmaceuticals, Inc
$275.48 from Medtronic MiniMed, Inc.
$269.63 from Tandem Diabetes Care, Inc.
$245.74 from GlaxoSmithKline, LLC.
$181.00 from Boehringer Ingelheim Pharmaceuticals, Inc.
$167.01 from Merck Sharp & Dohme Corporation
$128.82 from Abbott Laboratories
$121.36 from Animas Corporation
$106.41 from Amgen Inc.
$87.79 from Salix Pharmaceuticals, Ltd
$85.54 from MannKind Corporation
$68.39 from Corcept Therapeutics
Payments received by Dr. David Deibert, MD were from the following categories:
$6,708.77 Food and Beverage
$400.00 Consulting Fee
$243.12 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!